285 related articles for article (PubMed ID: 17658067)
1. [Monoclonal antibody therapy: a literature review].
Del Debbio CB; Tonon LM; Secoli SR
Rev Gaucha Enferm; 2007 Mar; 28(1):133-42. PubMed ID: 17658067
[TBL] [Abstract][Full Text] [Related]
2. Improving the efficacy of antibody-based cancer therapies.
Carter P
Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
[TBL] [Abstract][Full Text] [Related]
3. CTLA-4 blockade: autoimmunity as treatment.
Kapadia D; Fong L
J Clin Oncol; 2005 Dec; 23(35):8926-8. PubMed ID: 16204008
[No Abstract] [Full Text] [Related]
4. Combination epigenetic and immunotherapy overcomes resistance to monoclonal antibodies in hematologic malignancies: A new therapeutic approach.
Epner EM; Saroya BS; Hasanali ZS; Loughran TP
Exp Hematol; 2016 Mar; 44(3):157-60. PubMed ID: 26802532
[TBL] [Abstract][Full Text] [Related]
5. Update on monoclonal antibody therapy in chronic lymphocytic leukemia.
Zent CS; Kay NE
Clin Adv Hematol Oncol; 2004 Feb; 2(2):107-13. PubMed ID: 16163170
[TBL] [Abstract][Full Text] [Related]
6. New solid tumor targets for therapeutic monoclonal antibodies.
Papkoff J
Expert Opin Ther Targets; 2007 May; 11(5):585-8. PubMed ID: 17465718
[TBL] [Abstract][Full Text] [Related]
7. [Monoclonal antibodies and cancer].
López González JS; Selman Lama M
Salud Publica Mex; 1985; 27(3):213-34. PubMed ID: 2996157
[No Abstract] [Full Text] [Related]
8. [Principal therapeutic uses of monoclonal antibodies in oncology].
Penault-Llorca F; Etessami A; Bourhis J
Cancer Radiother; 2002 Nov; 6 Suppl 1():24s-28s. PubMed ID: 12587379
[TBL] [Abstract][Full Text] [Related]
9. Advances in immunotherapy of hematologic malignancies: cellular and humoral approaches.
Jurcic JG; Cathcart K; Pinilla-Ibarz J; Scheinberg DA
Curr Opin Hematol; 2000 Jul; 7(4):247-54. PubMed ID: 10882181
[TBL] [Abstract][Full Text] [Related]
10. Antibody-based therapeutics in oncology.
Ross J; Gray K; Schenkein D; Greene B; Gray GS; Shulok J; Worland PJ; Celniker A; Rolfe M
Expert Rev Anticancer Ther; 2003 Feb; 3(1):107-21. PubMed ID: 12597355
[TBL] [Abstract][Full Text] [Related]
11. [An overview of antibody-based cancer therapy].
Miao QF; Shao RG; Zhen YS
Yao Xue Xue Bao; 2012 Oct; 47(10):1261-8. PubMed ID: 23289136
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors.
Charmsaz S; Scott AM; Boyd AW
Exp Hematol; 2017 Oct; 54():31-39. PubMed ID: 28751189
[TBL] [Abstract][Full Text] [Related]
13. Antibody-based immunotherapy in high-risk neuroblastoma.
Johnson E; Dean SM; Sondel PM
Expert Rev Mol Med; 2007 Dec; 9(34):1-21. PubMed ID: 18081947
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody therapy for cancer.
Lovett DR; Scheinberg DA; Houghton AN
Cancer Chemother Biol Response Modif; 1991; 12():147-63. PubMed ID: 1931442
[No Abstract] [Full Text] [Related]
15. Bispecific monoclonal antibodies for the targeting of type I ribosome-inactivating proteins against hematological malignancies.
Ferrini S; Sforzini S; Canevari S
Methods Mol Biol; 2001; 166():177-92. PubMed ID: 11217367
[No Abstract] [Full Text] [Related]
16. [Monoclonal antibodies in the treatment of hematological malignancies].
Itälä M
Duodecim; 2002; 118(16):1647-56. PubMed ID: 12271942
[No Abstract] [Full Text] [Related]
17. Future prospects of monoclonal antibodies as magic bullets in immunotherapy.
Maleki LA; Baradaran B; Majidi J; Mohammadian M; Shahneh FZ
Hum Antibodies; 2013; 22(1-2):9-13. PubMed ID: 24284304
[TBL] [Abstract][Full Text] [Related]
18. Technology evaluation: edrecolomab, Centocor Inc.
Abicht A; Lochmüller H
Curr Opin Mol Ther; 2000 Oct; 2(5):593-600. PubMed ID: 11249762
[TBL] [Abstract][Full Text] [Related]
19. Intervention in receptor tyrosine kinase-mediated pathways: recombinant antibody fusion proteins targeted to ErbB2.
Wels W; Groner B; Hynes NE
Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():113-28. PubMed ID: 8815001
[No Abstract] [Full Text] [Related]
20. Immunotherapeutic approaches for hematologic malignancies.
Caligiuri MA; Velardi A; Scheinberg DA; Borrello IM
Hematology Am Soc Hematol Educ Program; 2004; ():337-53. PubMed ID: 15561691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
